Art

J-GLOBAL ID：201402289339154025   Reference number：14A0246528

Retrospective Analysis of Bevacizumab in Combination With Ifosfamide, Carboplatin, and Etoposide in Patients With Second Recurrence of Glioblastoma

膠芽腫の二次再発患者におけるイホスファミド,カルボプラチン,エトポシドとの併用でのベバシズマブの遡及的解析

Author (9)： ARAKAWA Yoshiki (Dep. of Neurosurgery, Kyoto Univ. Graduate School of Medicine) ,  MIZOWAKI Takashi (Dep. of Radiation Oncology and Image-applied Therapy, Kyoto Univ. Graduate School of Medicine) ,  MURATA Daiki (Dep. of Neurosurgery, Kyoto Univ. Graduate School of Medicine) ,  FUJIMOTO Koichi (Dep. of Neurosurgery, Kyoto Univ. Graduate School of Medicine) ,  KIKUCHI Takayuki (Dep. of Neurosurgery, Kyoto Univ. Graduate School of Medicine) ,  KUNIEDA Takeharu (Dep. of Neurosurgery, Kyoto Univ. Graduate School of Medicine) ,  TAKAHASHI Jun C. (Dep. of Neurosurgery, Kyoto Univ. Graduate School of Medicine) ,  TAKAGI Yasushi (Dep. of Neurosurgery, Kyoto Univ. Graduate School of Medicine) ,  MIYAMOTO Susumu (Dep. of Neurosurgery, Kyoto Univ. Graduate School of Medicine)
Material： Neurologia Medico-Chirurgica  (神経外科)
Volume： 53  Issue： 11  Page： 779-785 (J-STAGE)  Publication year： 2013 
JST Material Number： Z0762A  ISSN： 0470-8105  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *bevacizumab

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0246528&from=J-GLOBAL&jstjournalNo=Z0762A") }}

JST classification (3)： Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Tumors(=neoplasms)of nervous system  (GN04000V)

Substance index (2)： Ifosfamide ,  Etoposide

Reference (25)：

• AOKI, T. Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme. J Neurosurg. 2010, 112, 50-56
• CHINOT, O. Phase III trail of bevacizumab added to standard radiotherapy and temozolomide for newly-diagnosed glioblastoma : mature progeression-free surveival and prelonimnary over survival results in AVAglio. Neuro-oncol. 2012, 14, Suppl 6, 1-164
• FRANCESCONI, AB. Carboplatin and etoposide combined with bevacizumab for the treatment of rrecurrent glioblastoma multiforme. J Clin Neurosci. 2010, 17, 970-974
• FRIEDMAN, HS. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009, 27, 4733-4740
• GILBERT, MR. RTOG 0825 : Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM). J Clin Oncol. 31, Suppl ; abstr 1, 2013

Terms in the title (9)： 膠芽腫 ,  再発 ,  患者 ,  イホスファミド ,  カルボプラチン ,  エトポシド ,  併用 ,  ベバシズマブ ,  遡及的解析